|
1）Scott DA, Fisher AM. The Insulin and the Zinc Content of Normal and Diabetic Pancreas. J Clin Invest. 1938; 17: 725-8
|
|
|
|
2）Blundell TL, Cutfield JF, Cutfield SM, et al. Three-dimensional atomic structure of insulin and its relationship to activity. Diabetes. 1972; 21: 492-505
|
|
|
|
|
3）Brange J, Owens DR, Kang S, et al. Monomeric insulins and their experimental and clinical implications. Diabetes Care. 1990; 13: 923-54
|
|
|
|
|
|
4）Emdin SO, Dodson GG, Cutfield JM, et al. Role of zinc in insulin biosynthesis. Some possible zinc-insulin interactions in the pancreatic B-cell. Diabetologia. 1980; 19: 174-82
|
|
|
|
|
|
5）Boquist L, Lernmark A. Effects on the endocrine pancreas in Chinese hamsters fed zinc deficient diets. Acta Pathol Microbiol Scand. 1969; 76: 215-28
|
|
|
|
|
|
6）Huber AM, Gershoff SN. Effect of zinc deficiency in rats on insulin release from the pancreas. J Nutr. 1973; 103: 1739-44
|
|
|
|
|
|
7）Sladek R, Rocheleau G, Rung J, et al. A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature. 2007; 445: 881-5
|
|
|
|
|
|
8）Cauchi S, Del Guerra S, Choquet H, et al. Meta-analysis and functional effects of the SLC30A8 rs13266634 polymorphism on isolated human pancreatic islets. Mol Genet Metab. 2010; 100: 77-82
|
|
|
|
|
|
9）Boesgaard TW, Zilinskaite J, Vänttinen M, et al. The common SLC30A8 Arg325Trp variant is associated with reduced first-phase insulin release in 846 non-diabetic offspring of type 2 diabetes patients--the EUGENE2 study. Diabetologia 2008; 51: 816-20
|
|
|
|
|
|
10）Giacconi, R. Bonfigli AR, Testa R, et al. +647 A/C and +1245 MT1A polymorphisms in the susceptibility of diabetes mellitus and cardiovascular complications. Mol Genet Metab. 2008; 94: 98-104
|
|
|
|
|
|
11）Tamaki M, Fujitani Y, Uchida T, et al. Downregulation of ZnT8 expression in pancreatic beta-cells of diabetic mice. Islets. 2009; 1: 124-8
|
|
|
|
|
|
12）Murgia C, Devirgiliis C, Mancini E, et al. Diabetes-linked zinc transporter ZnT8 is a homodimeric protein expressed by distinct rodent endocrine cell types in the pancreas and other glands. Nutr Metab Cardiovasc Dis. 2009; 19: 431-9
|
|
|
|
|
|
13）Tamaki M, Fujitani Y, Hara A, et al. The diabetes-susceptible gene SLC30A8/ZnT8 regulates hepatic insulin clearance. J Clin Invest. 2013; 123: 4513-24
|
|
|
|
|
|
14）Nicolson TJ, Bellomo EA, Wijesekara N, et al. Insulin storage and glucose homeostasis in mice null for the granule zinc transporter ZnT8 and studies of the type 2 diabetes-associated variants. Diabetes. 2009; 58: 2070-83
|
|
|
|
|
|
15）Pound LD, Sarkar SA, Benninger RK, et al. Deletion of the mouse Slc30a8 gene encoding zinc transporter-8 results in impaired insulin secretion. Biochem J. 2009; 421: 371-6
|
|
|
|
|
|
16）Lemaire K, Chimienti F, Schuit F. Zinc transporters and their role in the pancreatic β-cell. J Diabetes Investig. 2012; 3: 202-11
|
|
|
|
|
|
17）Wijesekara N, Dai FF, Hardy AB, et al. Beta cell-specific Znt8 deletion in mice causes marked defects in insulin processing, crystallisation and secretion. Diabetologia. 2010; 53: 1656-68
|
|
|
|
|
|
18）Pound LD, Sarkar SA, Ustione A, et al. The physiological effects of deleting the mouse slc30a8 gene encoding zinc transporter-8 are influenced by gender and genetic background. PLoS One. 2012; 7: e40972
|
|
|
|
|
|
19）Ishihara H, Maechler P, Gjinovci A, et al. Islet beta-cell secretion determines glucagon release from neighbouring alpha-cells. Nat Cell Biol. 2003; 5: 330-5
|
|
|
|
|
|
20）Ghafghazi T, McDaniel ML, Lacy PE. Zinc-induced inhibition of insulin secretion from isolated rat islets of Langerhans. Diabetes. 1981; 30: 341-5
|
|
|
|
|
|
21）Ferrer R, Soria B, Dawson CM, et al. Effects of Zn2+ on glucose-induced electrical activity and insulin release from mouse pancreatic islets. Am J Physiol. 1984; 246: C520-7
|
|
|
|
|
|
22）Bancila V, Cens T, Monnier D, et al. Two SUR1-specific histidine residues mandatory for zinc-induced activation of the rat KATP channel. J Biol Chem. 2005; 280: 8793-9
|
|
|
|
|